Acutaas Chemicals Limited
Acutaas Chemicals Limited (ACUTAAS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
acutaas.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 172 Cr | 166 Cr | 225 Cr | 177 Cr | 247 Cr | 275 Cr | 308 Cr | 207 Cr | 306 Cr | 393 Cr | 433 Cr | 330 Cr |
| Operating expenses (approx.) | 148 Cr | 140 Cr | 182 Cr | 147 Cr | 198 Cr | 206 Cr | 224 Cr | 156 Cr | 211 Cr | 243 Cr | 249 Cr | 217 Cr |
| EBITDA | 25 Cr | 27 Cr | 43 Cr | 30 Cr | 49 Cr | 69 Cr | 85 Cr | 51 Cr | 95 Cr | 151 Cr | 184 Cr | 113 Cr |
| OPM % | 14.4% | 15.9% | 19.2% | 16.7% | 19.8% | 25.0% | 27.5% | 24.6% | 31.1% | 38.3% | 42.4% | 34.3% |
| Other income | 2 Cr | 3 Cr | 1 Cr | 1 Cr | 8 Cr | 2 Cr | 6 Cr | 16 Cr | 10 Cr | 5 Cr | 11 Cr | 2 Cr |
| Interest | 0.82 Cr | 3 Cr | 2 Cr | 4 Cr | 0.50 Cr | 0.69 Cr | 0.60 Cr | 0.64 Cr | 0.58 Cr | 0.86 Cr | 1 Cr | 1 Cr |
| Depreciation | 4 Cr | 4 Cr | 5 Cr | 6 Cr | 7 Cr | 6 Cr | 7 Cr | 8 Cr | 8 Cr | 10 Cr | 10 Cr | 10 Cr |
| Profit before tax | -10 Cr | 24 Cr | 37 Cr | 20 Cr | 50 Cr | 63 Cr | 83 Cr | 58 Cr | 96 Cr | 145 Cr | 184 Cr | 104 Cr |
| Tax % | -71.2% | 24.9% | 31.0% | 26.4% | 24.9% | 28.2% | 24.3% | 24.2% | 25.3% | 26.6% | 26.9% | 27.8% |
| Net profit | -17 Cr | 18 Cr | 26 Cr | 15 Cr | 38 Cr | 45 Cr | 63 Cr | 44 Cr | 72 Cr | 106 Cr | 134 Cr | 75 Cr |
| EPS (₹) | ₹-4.67 | ₹4.83 | ₹6.86 | ₹3.67 | ₹9.38 | ₹11.35 | ₹7.80 | ₹5.41 | ₹8.82 | ₹13.19 | ₹16.09 | ₹9.07 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 520 Cr | 617 Cr | 717 Cr | 1,007 Cr | 1,339 Cr | Sign in for TTM |
| Operating expenses (approx.) | 415 Cr | 494 Cr | 589 Cr | 775 Cr | 859 Cr | Sign in for TTM |
| EBITDA | 105 Cr | 123 Cr | 128 Cr | 232 Cr | 480 Cr | Sign in for TTM |
| OPM % | 20.2% | 19.9% | 17.9% | 23.0% | 35.9% | Sign in for TTM |
| Other income | 3 Cr | 4 Cr | 7 Cr | 17 Cr | 42 Cr | Sign in for TTM |
| Interest | 6 Cr | 2 Cr | 6 Cr | 6 Cr | 3 Cr | Sign in for TTM |
| Depreciation | 10 Cr | 12 Cr | 16 Cr | 27 Cr | 36 Cr | Sign in for TTM |
| Profit before tax | 91 Cr | 112 Cr | 82 Cr | 216 Cr | 483 Cr | Sign in for TTM |
| Tax % | 21.3% | 25.7% | 40.5% | 25.8% | 26.2% | Sign in for TTM |
| Net profit | 72 Cr | 83 Cr | 49 Cr | 160 Cr | 356 Cr | Sign in for TTM |
| EPS (₹) | ₹21.03 | ₹22.86 | ₹11.67 | ₹19.81 | ₹43.51 | Sign in for TTM |
| Dividend payout % | 0.0% | 13.1% | 22.4% | 7.7% | 3.4% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 36 Cr | 36 Cr | 37 Cr | 41 Cr | 41 Cr |
| Reserves | 486 Cr | 558 Cr | 637 Cr | 1,269 Cr | 1,613 Cr |
| Borrowings | 0.84 Cr | 4 Cr | 217 Cr | 8 Cr | 26 Cr |
| Other liabilities | 136 Cr | 169 Cr | 196 Cr | 221 Cr | 247 Cr |
| Total liabilities | 659 Cr | 767 Cr | 1,096 Cr | 1,549 Cr | 1,984 Cr |
| Fixed assets (net) | 158 Cr | 222 Cr | 360 Cr | 505 Cr | 633 Cr |
| CWIP | 3 Cr | 26 Cr | 125 Cr | 130 Cr | 332 Cr |
| Investments | 2 Cr | 2 Cr | 0.20 Cr | 0.20 Cr | 0.20 Cr |
| Loans & advances | 0.65 Cr | 1 Cr | 2 Cr | 2 Cr | 3 Cr |
| Inventories | 112 Cr | 119 Cr | 157 Cr | 180 Cr | 231 Cr |
| Trade receivables | 164 Cr | 230 Cr | 206 Cr | 290 Cr | 363 Cr |
| Cash & bank | 10 Cr | 31 Cr | 30 Cr | 185 Cr | 216 Cr |
| Other assets | 209 Cr | 137 Cr | 216 Cr | 256 Cr | 206 Cr |
| Total assets | 659 Cr | 767 Cr | 1,096 Cr | 1,549 Cr | 1,984 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | -9 Cr | 66 Cr | 125 Cr | 118 Cr | 292 Cr |
| Cash from investing | -124 Cr | -33 Cr | -365 Cr | -224 Cr | -266 Cr |
| Cash from financing | 140 Cr | -12 Cr | 239 Cr | 261 Cr | 4 Cr |
| Net cash flow | 8 Cr | 20 Cr | -0.83 Cr | 156 Cr | 30 Cr |
| Free cash flow (OCF − Capex) | -9 Cr | -31 Cr | -155 Cr | -76 Cr | -36 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 18.7% | 19.2% | 9.8% | 16.7% | 28.0% |
| ROE % | 13.8% | 0.0% | 6.3% | 12.0% | 20.8% |
| Debtor days | 115 | 136 | 105 | 105 | 99 |
| Inventory days | 145 | 125 | 130 | 115 | 142 |
| Days payable | 153 | 150 | 112 | 100 | 94 |
| Cash conversion cycle | 107 | 112 | 123 | 120 | 146 |
| Debt / equity | 0.0016 | 0.0061 | 0.32 | 0.0062 | 0.02 |
| Current ratio | 3.32 | 2.89 | 1.74 | 3.91 | 3.82 |
| Net debt / EBITDA | 0.00 | -0.22 | 1.45 | -0.76 | -0.39 |
Compare with peers
Loading peers…